ArticleBMC pediatrics2025
M6A Methylase METTL3-mediated downregulation of TEP1 mRNA stability attenuates PDGF-BB-induced HASMC remodeling and inflammation via macrophage polarization.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Canonical and emerging regulatory mechanisms of tissue remodeling: shared principles across organs and therapeutic opportunities.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChildhood asthma is a chronic inflammatory disease of the respiratory tract characterized by the contraction of smooth muscle, remodeling of the airway wall, bronchial inflammation, and obstruction, which is associated with increased airway smooth muscle mass. Telomerase Associated Protein 1 (TEP1) was reported to be aberrantly expressed in childhood asthma. Therefore, this study is designed to explore the role and mechanism of TEP1 on the pathogenesis of asthma.
methodsAsthma cell models were established using Platelet-derived growth factor-BB (PDGF-BB) in Human airway smooth muscle cells (HASMCs). TEP1 and Methyltransferase-like 3 (METTL3) levels were detected by real-time quantitative polymerase chain reaction (RT-qPCR). TEP1, autophagic markers (Beclin1, LC3II/LC3I, and P62), and contraction phenotypic markers (Calponin, SM22α, and α-SMA), M2-like macrophage markers (IRF4, CD206, and Arg-1), and METTL3 protein levels were examined by western blot assay. Cell viability and migration were assessed using CCK-8 and transwell assays. The proportion of iNOS and CD206 positive cells was detected using flow cytometry. The levels of IFN-γ, IL-4, and IL-10 were detected using ELISA. Interaction between METTL3 and TEP1 was verified using methylated RNA immunoprecipitation (MeRIP).
resultsTEP1 was highly expressed, and METTL3 was decreased in asthma patients and PDGF-BB-treated HASMCs. TEP1 knockdown relieved PDGF-BB-induced proliferation, migration, autophagy promotion, and contractile phenotype inhibition in HASMCs. Meanwhile, PDGF-BB-mediated M1-like macrophage polarization decrease and M2-like macrophage polarization increase were abolished by TEP1 silencing. Mechanistically, METTL3 could reduce the stability of TEP1 mRNA via m6A methylation.
conclusionMETTL3 destabilizes TEP1 mRNA in an m6A-dependent manner, thereby relieving PDGF-BB-triggered HASMC proliferation, migration, autophagy, loss of contractile phenotype, and M2-like macrophage activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.